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Background: Anomalous aortic origin of the coronary artery (AAOCA) from the opposite sinus of Valsalva with an
interarterial course has received much attention due to its association with sudden death in otherwise healthy
individuals. AAOCA is relatively common and may have significant public health implications. While our knowledge
of its pathophysiology and natural history remains incomplete, an emphasis has been placed on surgical correction.
Discussion: In 2005 we published a review examining the rates of sudden death with AAOCA, as well as
complications of surgical management. Evidence now points even more strongly to lower rates of sudden death,
while surgical outcomes data now better documents associated risks.
Summary: Armed with this updated information, we agree with the need for a national registry to better track
patients with AAOCA. We submit that the risks of surgical management outweigh any benefits in the asymptomatic
patient with anomalous right coronary artery, and expectant management should also be strongly considered even
in asymptomatic patients with anomalous left coronary artery.
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Anomalous aortic origin of the coronary artery arising
from the opposite sinus (AAOCA) has received much at-
tention due to its association with sudden cardiac death
(SCD). It is believed to be relatively common and is thus
a potentially serious public health hazard. Indeed, many
groups opt for surgical “repair” of AAOCA when the cor-
onary artery takes an intramural and/or interarterial
course even if a patient is asymptomatic. In a critical ana-
lysis in 2005, we concluded that the intrinsic risk of
AAOCA was far lower than perceived and that surgical
risks were not insignificant [1]. Since that time, import-
ant data have emerged on both the rates of SCD in other-
wise healthy individuals with AAOCA and surgical
outcomes. The goals of this paper are three-fold: 1) to re-
view briefly the diagnosis and presumed pathophysiology
of AAOCA; 2) to show recent data supporting our argu-
ment that the risk of SCD is far lower than many believe;
and 3) to analyze recent surgical data, which cast serious* Correspondence: colin.phoon@nyumc.org
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The history of AAOCA has been extensively reviewed.
Cheitlin et al. in their 1974 paper demonstrated that an
anomalous left coronary artery arising from the right
sinus of Valsalva (ALCA) can cause SCD [2]. Others
have reported that an anomalous right coronary artery
arising from the left sinus of Valsalva (ARCA) can also
lead to SCD and have concluded that it too should be
considered a potentially dangerous anomaly [3-5].
Several theories have been developed to explain the
mechanism of SCD in patients with AAOCA. One theory
focuses on the acute angle of takeoff and resultant slit-
like orifice and kinking of the anomalous vessel [3,5-7]
which, during exercise, may occlude as the aorta
expands, leading to an acute ischemic event [2]. Others
postulate that increased flow through the aorta and the
pulmonary artery during exertion can compress the cor-
onary artery thus obstructing flow [2,3]. Additionally,
Basso and her colleagues state that ischemia likely occursl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and subsequent foci for lethal ventricular arrhythmias.
This theory is supported by histologic evidence of
chronic ischemic changes in areas of myocardium sup-
plied by the anomalous coronary vessels [8,9]. Intravas-
cular ultrasound (IVUS) has demonstrated that
intussuception, coronary hypoplasia and lateral compres-
sion of the coronary wall by the aorta may contribute to
compromised perfusion [10,11]. We also believe restric-
tion of flow through the relatively noncompliant “peri-
commissural” area may also be a factor. It is theorized
that any of these mechanisms individually or in the ag-
gregate could be potentiated by changes in blood flow
during exercise and could thereby lead to SCD.
Diagnosis
Patients with AAOCA are typically asymptomatic. The
diagnosis is often made as an incidental finding. Symp-
tomatic patients complain of exertional syncope, chest
pain, or palpitations [8]. The physical exam, ECG and
exercise stress testing are generally unremarkable [8,12].
Because coronary angiography has a significant false
negative rate [13,14], other imaging modalities are fre-
quently employed. In particular, multidetector computed
tomography (CT) scanners and magnetic resonance
angiography (MRA) now provide excellent spatial reso-
lution allowing visualization of the coronary anatomy
[15-18] and have been used to diagnose AAOCA in
patients who had previously “normal” angiograms
[19,20]. One study demonstrated that gadolinium-
enhanced MRA in adults can be used to assess scar bur-
den in the area supplied by an anomalous right coronary
artery, which may have prognostic value in the future
[21]. Advances in CT technology have reduced the radi-
ation exposure and ameliorated the need for heart rate
control with beta-blockers [20]. In the pediatric popula-
tion, even with lower radiation doses, the risk of expos-
ure limits the usefulness of CT. The American Heart
Association in its recent statement on noninvasive im-
aging of coronary arteries in the young recommends
MRA over angiography and CT in assessing for anomal-
ous coronary arteries [22].Table 1 Five representative autopsy studies (adapted from M
Author N ARCA ALCA
Chietlin et al., 1974 [2] 51 18 33
Taylor et al., 1992 [7] 30 21 9
Kragel and Roberts, 1988 [36] 32 25 7
Taylor et al., 1997 [4] 101 52 49
Frescura et al., 1998 [5] 11 7 4
TOTAL 225 123 102
Abbreviations: ARCA=Anomalous right coronary artery from the left sinus; ALCA =AIn children, transthoracic echocardiography (TTE) is
arguably the most useful tool in screening for this condi-
tion and often leads to the diagnosis without additional
imaging [23-26]. TTE is non-invasive, does not employ
radiation and can be performed without sedation. It
allows for direct visualization of the origins of the vessels
[27] and when aided by the use of color Doppler can
demonstrate an intramural course that might otherwise
be missed [28]. Clearly, as technology improves the value
of any single modality in assessing this condition may
change. We, like many groups, have often correctly diag-
nosed this condition using TTE but prefer additional
supplemental imaging modalities both to confirm this
important diagnosis and to delineate specific details of
the anatomy.
Prevalence
The true prevalence of this condition is difficult to ascer-
tain. Published data suggests that the rate of anomalous
coronary arteries arising from the opposite sinus to be in
the range of 0.1%-0.3% [23,24,29,30]. In one prospective
angiographic study involving 1,950 patients by Angelini
et al., the authors found the incidence to be as high as
1.07% [31]. For the purposes of this paper we will use a
conservative estimate of 0.1-0.2%. ARCA is estimated to
be six to ten times more common then ALCA [29,31].
Risk of sudden death with AAOCA
In this section we will update estimates of the risk of
SCD with AAOCA and challenge the assumption that
the risk of dying suddenly is high, as continues to be
cited by many authors [18,32-35].
Estimates on rates of SCD with this condition come al-
most exclusively from autopsy data. Based on several
autopsy studies, mortality “rates” have been reported to
range between 0%-50% with ARCA and 30%-100% with
ALCA [2,4,5,7,36]. The results of several often-quoted
autopsy papers are summarized in Table 1. These num-
bers are inherently biased by the selected population: the
deceased. The numbers reported reflect the prevalence
of AAOCA in those who have already died, not the risk
of death of those living with anomalous coronary vessels.irchandani and Phoon, 2005)
Sudden deaths attributed to anomalous coronaries
Right Left
0/18 (0%) 9/33 (27%)
4/21 (19%) 8/9 (89%)
8/25 (32%) 5/7 (71%)
13/52 (25%) 28/49 (57%)
4/7 (57%) 4/4 (100%)
29/123 (24%) 54/102 (53%)
nomalous left coronary artery from the right sinus.
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can males age 15-24-years-old is 12% because of the
35000 deaths annually in this age group, 4200 were from
suicide [37]. Clearly (and thankfully), 1 in 8 males in this
age group do not commit suicide.
The actual risk of dying from either ARCA or ALCA
must be far lower if one is to believe the prevalence of
the disease in the general population. As reported above,
prospective screening data estimates 0.1-0.2% of the
population have this anomaly. The current US popula-
tion is ~309 million [38]. Thus, an estimated 300,000-
600,000 people currently live in the United States with
AAOCA. Further, the annual birth rate in the United
States is ~4.3 million [39] suggesting that there are ap-
proximately 4000–8000 infants born with AAOCA every
year. Clearly, if children and young adults were dying at
the rates predicted by autopsy reports, SCD in the young
would be a much more common event.
Several studies have indicated that risk of death with
this lesion is far lower than what has often been cited
based on autopsy studies. In 2000, Wren, O’Sullivan and
Wright [40] published on all deaths at age 1–20 over a
10-year period in the Northern Health Region of
England. The reported population was nearly 800,000
and over the study period provided just over eight mil-
lion person-years. During that time there were 270 sud-
den deaths, none of which was attributed to AAOCA.
Of note, 41 of these deaths remained unexplained des-
pite necropsy. Using a conservative estimate of 0.1-0.2%,
one would expect approximately 800–1,600 individuals
living with AAOCA in the region. This study did not
evaluate deaths in those older than 20, though certainly
such individuals with AAOCA are still at risk for SCD.
Additionally, the cause of 41 deaths remains uncertain.
Eckart et al. studied death rates in military recruits
during boot camp over a 25-year period [41]. The
authors looked at all non-traumatic deaths with available
autopsy data. From a population of greater than 6 mil-
lion military personnel, 21 deaths were associated with
AAOCA; all were ALCA. The incidence of SCD attribut-
able to anomalous coronary arteries in the studied popu-
lation was ~ 1/300,000 (0.0003%). Reasonably, 0.1-0.2%
of this population would be expected to have AAOCA –
or approximately 6,000-12,000 of the military recruits.
Therefore, the risk of death with this condition could be
estimated to be 0.17-0.35% (21/6,000-12,000) in indivi-
duals engaged in frequent vigorous exercise. Of note,
this data was collected during a short period of time in
each individual’s life and as such it does not account for
death that occurs at a later time.
Corrado and his group evaluated cardiovascular causes of
sudden death in young athletes in the Veneto region of Italy
from 1979 to 2004 [42]. This study, which was designed
primarily to assess the effectiveness of preparticipationscreening, elucidates the risk of sudden cardiac death from
AAOCA. The Veneto region is a homogenous, geographic-
ally well-defined region in which all fatalities in people
35 years or younger are investigated. The authors focused
on all sudden cardiovascular deaths in people age 12–
35 years old during the 26-year study period. They reported
that during that time, the rate of death from congenital cor-
onary anomalies was 0.24 per 100,000 person years. This
number includes deaths from all forms of congenital cor-
onary anomalies and therefore is higher than the rate of
death specifically from AAOCA. Regardless, the number is
far lower than that reported by autopsy data.
Maron and his colleagues provide a comprehensive
analysis of sudden deaths among competitive athletes in
the United States over a 27-year period [43]. The authors
used several methods to identify these events. These
included: 1. LexisNexis archives; 2. News accounts; 3.
Internet searches; 4. Reports from the US Consumer
Product Safety Commission; 5. Records from the Na-
tional Center for Catastrophic Sports Injury Research; 6.
Pathology archives; 7. Direct reporting. There were 1866
episodes of sudden death among U.S. athletes (which
includes 85 survivors of cardiac arrest) over the 27 years.
Of these, 1049 were attributed to a cardiovascular cause
and 119 (~11% of the cardiovascular deaths) were attrib-
uted specifically to AAOCA. This study is more compre-
hensive than that of Eckart’s group in that it looks at
rates of SCD over an extended period of time. Those ath-
letes who continued to involve themselves in sports
remained in this study. Based on their data, the authors
report the incidence of sudden cardiovascular mortality
0.61/100,000 person-years (of which anomalous coronar-
ies account for ~11% or 0.07/100,000 person-years). A
further analysis was conducted by Brothers and her
group using this same data and they determined that the
cumulative risk of death over a 20-year period from the
age of 15–35 (the highest risk period) in patients with
AAOCA was 6.3% for ALCA and 0.2% for ARCA [44].
These analyses are prone to ascertainment bias and
underreporting, and may therefore underestimate the
true risk of SCD. But, the risk of death with AAOCA
remains far lower than what is often cited.
A comprehensive study was conducted by Harmon
et al. reviewing SCD in National Collegiate Athletic As-
sociation (NCAA) student-athletes from 2004–2008
[45]. The advantages of this study over Maron’s was the
ability of the authors to more precisely determine the
number of athletes involved in college athletics during
the study period. While autopsy data and therefore spe-
cific diagnosis were not provided, the authors did find a
nearly four-fold higher rate of SCD when compared to
Maron’s results. Interpreting this data is difficult without
autopsy results, but estimating that ~10% of those epi-
sodes of SCD may have been due to AAOCA (based on
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(~1:430,000 person-years). Note that this is the risk of
all student-athletes dying from AAOCA from the op-
posite sinus. If we assume a 0.2% prevalence of AAOCA
in the general population, then the risk if a student-
athlete actually has an AAOCA from the opposite sinus
becomes 1:860 person-years (0.12%); this number is re-
markably consistent with other estimates presented in
this paper. Additional smaller studies have reported on
SCD rates in various populations and lend further sup-
port the findings of Wren, Corrado, Eckart, Maron and
Harmon. These studies are summarized in Table 2.
Both Eckart’s and Maron’s studies focused on popula-
tions (military recruits and athletes) that are by definition
involved in a high level of physical activity. These rates of
SCD are likely higher than are to be expected for the US
population in general since only the minority of U.S. resi-
dents meets minimum exercise requirements [49,50]. In
actuality, there are approximately 3.7 million competitive
athletes involved in high-risk activities annually [51],
representing only a fraction of the total US population.
Physical exertion is thought to significantly increase
risk of SCD based on the reported cases and the pre-
sumed pathophysiology. Those not involved in competi-
tive sports or physically demanding jobs are at lower
risk of SCD. In 2000, Basso and her colleagues published
a review of all sudden deaths reported in a large US and
Italian registry. 27 deaths were attributed solely to
anomalous coronary arteries (23 due to ALCA, 4 due to
ARCA). All the deaths occurred during or immediately
after strenuous athletic activity [8]. Corrado and his
group, from the Veneto region of Italy as discussed
above, demonstrated that the risk of sudden cardiacTable 2 Reports on rates of sudden death
Author Population studied Total population
(n)
Wren et al., 2000 [40] All children 1-20yo in Northern
Health Region, England
806,000
Eckart et al., 2004 [41] All US military recruits 6,300,000





Marathoners from 26 selected
US marathons
3,292,268
Maron et al., 2009 [43] All competitive US athletes Not available
Chugh et al., 2009 [47] All children 0-17yo in
Multnomah County, OR
660,486*
Harris et al., 2010 [48] All triathletes in USA Triathalon
sanctioned events
959,214
Harmon et al., 2011 [45] All NCAA athletes 393,932}
* Total population of Multnomah County, OR including children and adults.
† Officially listed cause of death “drowning” (during a triathalon event) but cardiac
{ Study only looked at cardiovascular causes of sudden death.
} Total population derived by dividing “athelete participation years” by the 5-year sdeath from coronary anomalies is increased 3 to 6 fold
with athletic activity [42]. Thiene et al. reported a three-
fold increase in SCD (from all causes) among athletes
when compared to non-athletes [9]. The risk of SCD
reported in Eckart’s and Maron’s studies may therefore
be high relative to the general population.
Is risk stratification of patients possible?
AAOCA receives a disproportionate amount of media
attention because of its association with SCD in other-
wise healthy and often asymptomatic individuals. Identi-
fying specific attributes associated with those who die
from this condition would help with risk stratification
and prognosis. Several authors have attempted to iden-
tify specific factors that might portend a higher likeli-
hood of SCD. Anatomic characteristics that have been
discussed as possibly contributing to the risk of death in-
clude those features already listed above, namely: angle
of takeoff; intramural course; slit-like ostium; interarter-
ial course; vessel spasm and intussusception of the
anomalous vessel [10,12]. In an attempt to identify spe-
cific features that were thought to contribute to risk of
death, Taylor et al. looked at 30 pathology cases of
anomalous left and right coronary arteries. The authors
were unable to identify any specific anatomical features
that correlated with an increase risk of demise. The
authors concluded that there were no anatomic features
that could aid in risk assessment [4].
Based on their evaluation using IVUS in symptomatic
patients with ALCA, Angelini and his colleagues have
postulated that a subset of patients with intussusception
of the anomalous coronary are at high risk for SCD








1985-1994 (10 years) 270 26 0
1977-2001 (25 years) 126 64 21
1979-2004 (26 years) N/A{ 320 21
1975-2004 (30 years) 26 21 2
1980-2006 (27 years) 1866 1049 119
2002-2005 (3 years) 8 3 0
2006-2008 (3 years) 14 7† 1†
2004-2008 (5 years) 80 45 N/A}
abnormalities were identified and thought to be the causative factor.
tudy period. The study did not report on specific causes of cardiac death.
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hypoplasia of the intramural segment; amount of lateral
compression of intussuscepted segment; degree of lateral
compression during periods of exertion. Ultimately they
hope to use their findings to facilitate clinical decision-
making. Its use in children may be limited due to the in-
vasive nature of cardiac catheterization and IVUS, lack
of experience using this technique in children leading to
increased procedural risk, and limitations in catheter
size for use in children.
The only variable that seems to consistently correlate
with risk of SCD is age < 30 years [4,12]. While the risk
decreases with age, the exact reason is unclear. Angelini
has suggested that this may be due to the stiffening of
the aortic wall with age, which might help protect
against compression of the intramural course [12]. The
risk of SCD under the age of 10 is also low [44,54,55].
There is a general consensus among those who have
published on this topic that more information is needed
to aid in assigning risk [4,12,56]. Recently, the Registry
of Anomalous Aortic Origin of the Coronary Artery was
established to compare surgical versus observational out-
comes and try to identify subsets of patients who would
benefit from one approach over the other [57].Surgical strategies
Currently, many patients undergo surgery as the primary
treatment strategy for this condition. This is particularly
true in all cases of ALCA and the symptomatic patient
with ARCA and has been supported by a consensus
statement in the Guidelines for Management of Adults
with Congenital Heart Disease [58].
There are multiple surgical options for treating
AAOCA. Bypass grafting was used initially [59,60]. How-
ever, early graft failure was reported in several cases.
Tavaf-Motamen and colleagues theorized that the early
failure is due to steal phenomenon at high levels of exer-
tion [61] or competitive flow from patent native vessels
contributing to graft thrombosis [62,63]. For this reason
bypass grafting has been used less frequently. Other
approaches have included reimplantation of the anomal-
ous vessel into its appropriate sinus [31,64], patch aug-
mentation [65,66] or pulmonary artery translocation to
reduce the risk of compression of the anomalous vessel
as it traverses between the aorta and the pulmonary ar-
tery [67].
More recently, unroofing the anomalous vessel along
its intramural segment has become the preferred man-
agement option [61,68-70]. This procedure, first
reported by Mustafa in 1981, creates a neo-orifice at the
anatomically correct sinus [71]. The advantages of
unroofing are that it eliminates the intramural segment
and avoids an oblique angle of take-off of the vessel.Some surgeons advocate a tailored approach that
depends on the specific anatomic variant [66].
The unroofing technique has been highly touted for
several years. However, examination of the surgical lit-
erature indicates that surgical correction is not without
risks. Romp and his colleagues looked at complications
associated with the unroofing procedure [70]. The
authors prospectively evaluated 9 consecutive patients
who underwent surgical repair for anomalous origin of
the coronary artery (6 ALCA and 3 ARCA) between
1995 and 2001. Of these 9 patients, 7 underwent an
unroofing procedure while 2 had neo-ostial creation
without unroofing. Though the authors did not find
postoperative ischemia on stress testing, out of the 9
patients studied 1 developed severe aortic insufficiency
and required aortic valve replacement.
Brothers and her coworkers, in their 2007 prospect-
ive study, reported on myocardial ischemia after surgi-
cal repair of an anomalous coronary artery [56]. The
authors reviewed the records of 24 patients who
underwent surgical correction of anomalous coronary
arteries from the opposite sinus (8 ALCA and 16
ARCA) between 2001 and 2006. Preoperatively, of the
24 patients reviewed one patient had a “blunted blood
pressure response” on exercise stress test without EKG
changes, one had premature ventricular contractions
on Holter monitoring and one had an episode of
aborted sudden death. Postoperatively, out of the 24
patients, 9 (38%) had evidence of ischemic changes on
exercise stress testing, myocardial perfusion scans, or
stress echocardiograms that were not seen preopera-
tively – including 8/16 for ARCA. It should be noted
that the same postoperative stress testing regimen had
not been uniformly applied preoperatively, making ab-
solute comparisons difficult. These findings are worri-
some for the following reasons: 1. If they indicate a
false positive, then it makes it difficult to follow these
patients after surgery 2. If they are truly an indication
of compromised myocardial perfusion, then the oper-
ation may be responsible for causing injury in patients
who did not have it previously. It is unknown if this
operative strategy has altered the natural history of
sudden cardiac death, but the results are troubling.
The authors concluded only that more information is
needed in order to weigh the long-term risks of the
anomaly against the long-term risks of surgery.
In a survey conducted by the Anomalous Coronary
Artery Working Group [72], post-operative complica-
tions included valvular regurgitation, left ventricular dys-
function, chronic pericarditis, pericardial effusion and
possible small infarct. In addition, 2 deaths occurred
after surgery for this condition: a 7-year-old several
weeks after unroofing and a 5-year-old who died within
the first postoperative week. No specifics were available
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emphasize the infrequent but inherent risks of surgery.
Several authors have examined outcomes after surgical
management of AAOCA. These often involve small
numbers of patients over a relatively short follow-up
period and we therefore summarize the results in Table 3.
The majority of the patients in these studies are adults
with comorbid conditions that undoubtedly contribute
to operative risk. Children would likely fare better, but
require coronary patency for several decades.Table 3 Outcomes of surgical management of AAOCA and stu




Romp et al., 2003 [70] 9 (3/6) 2.4 Valvu
Garcia-Rinaldi et al.,
2004 [73]
16 (16/0) 6.8 Graft
Erez et al., 2006 [32] 9 (5/4) 1 None
Alphonso et al., 2007 [74] 4 (2/2) 1.9 None
Brothers et al., 2007 [56] 24 (16/8) 1.25 Ische
peric
Fedoruk et al., 2007 [75] 5 (5/0) 1 RV dy
air em










4 (4/0) 0.8 Graft
Davies et al., 2009 [77] 36 (21/15) 1.1 Atrial
subd
(died
elZein et al., 2009 [78] 8 (6/2) 1.2 None
Frommelt et al., 2011 [79] 27 (20/7) 1.8 None
Krasuski et al., 2011* [80] 28 (20/8) 8.2 None
Mainwaring et al.,
2011 [81]




Mumtaz et al., 2011 [82] 22 (15/7) 1.4 None
Abbreviations: ARCA=Anomalous right coronary artery from the left sinus; ALCA=A
* Mortality was the only outcome assessed, all other studies listed reported on morNon-surgical strategies
A small number of case reports claim successful use of
beta-blockers in adults to treat this condition [83-86].
One study treated 56 adult patients with AAOCA and
reported no episodes of SCD over a 5-year period [87].
Ouali and his team in Tunisia – where bypass grafting is
currently the only surgical option – report that of 16
patients with AAOCA treated with beta-blockers and
angiotensin-converting enzyme inhibitors, all are alive
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- Small N
- Reimplantation only
- All patients >30yo





7 (not specified) - Short follow-up
- No postoperative
stress testing reported





0 (0/0) - Short follow-up







8 (not specified) - No postoperative
stress testing reported




nomalous left coronary artery from the right sinus.
bidity and mortality.
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cessful medical management must be tempered by the
rarity of SCD, particularly in adults, and over such short
follow-up periods.
A large number of individual case reports have been
published on the use of stents to manage AAOCA in
adults [89-93]. In 2000, Doorey and his colleagues
reported on a series of 14 AAOCA patients who were
successfully stented [94]. All patients had objective evi-
dence of ischemia that resolved after the intervention.
While stenting may have utility, it is difficult to draw
conclusions from the scant data available. Further, it has
limited application in growing children.
Guidelines in managing this condition focus on the
association between SCD and exercise. The American
Heart Association /American College of Cardiology
(AHA/ACC) have recommended against participation
in all competitive sports for patients with AAOCA
[95]. To what degree a given activity is thought to
comprise a competitive sport is debatable. Certain
behaviors are an important part of child development
and this is reflected in the recommendation that they
participate in physical education classes and other
“non-strenuous” physical activities but discourage more
rigorous organized team sports [1]. Further, Corrado’s
data, discussed above, demonstrates that while the risk
of SCD is increased with exercise, there is still a risk
of SCD even at rest. No distinction is made in the
AHA /ACC guidelines between ALCA and ARCA,
despite the knowledge that ALCA is the higher-risk le-
sion. Twenty-seven percent of respondents to Brothers
and her colleagues’ questionnaire on management of
AAOCA reported they prevent competitive sports par-
ticipation but otherwise allow exercise [72].
Intervention: proceed with caution
Like all management decisions, the advantages of the
intervention must be weighed against possible adverse
consequences. In the case of AAOCA of either (right or
left) origin the data at first glance is compelling for sur-
gical intervention. The perceived “risk” of death still
cited by many (but derived from autopsy data) suggests
a dire outcome if left untreated. Incidence of SCD in the
general population, however, undermines the autopsy
data. After our initial cautionary review [1], Gersony
followed-up with a compelling argument against surgical
management of ARCA in the asymptomatic patient [54].
He cited the low incidence of death from this condition
in multiple studies and the risk of ischemia after surgery
reported in Brothers and her coworkers’ study [56].
Others have now echoed this position. Lytrivi and her
colleagues have questioned the utility of operating on all
patients with ARCA and ALCA given the rarity of SCD
and lack of knowledge on the exact mechanism [96].Osaki and his group advocate expectant management
and frequent reassessment in asymptomatic patients
with AAOCA [26]. Cheitlin and MacGregor have argued
that the risks of surgery outweigh the risks of SCD in
asymptomatic patients with ARCA and therefore advise
against it. They also advocate discussing with the patient
and family the risks of both SCD and surgery when
planning management of the patient with asymptomatic
ALCA [97]. These authors are not alone, as nearly
twenty-five percent of respondent to Brothers’ recent
survey on management of AAOCA do not refer asymp-
tomatic patients for surgery [72].
The comprehensive reviews of sudden death discussed
above, as well as those listed in Table 2, have, in our
opinion, helped to tip the balance toward observation of
the asymptomatic patient.a Further, while the proposed
mechanisms by which people with ARCA or ALCA die
suddenly are compelling, none are certain. There exists
the possibility that surgical correction is not a definitive
therapy and these patients may still be at risk of coron-
ary compromise or arrhythmias that short-term studies
have not yet captured. In short, surgery may not be the
answer to this condition and in operating on all patients
with AAOCA we may be doing more harm than good.
Suggested management guidelines
Based on the data presented in this paper, we summarize
our recommendations as follow:
 Symptomatic ARCA or ALCA with evidence of
myocardial ischemia: Surgical intervention. Prior to
surgical intervention we recommend restriction
from competitive sports or other recreational
activities that approach the level of exertion seen in
organized sports.
 Asymptomatic ARCA: We are concerned that the
risks of surgery outweigh the potential benefits and
therefore advise against surgical intervention, but we
recommend restriction from competitive sports or
other recreational activities that approach the level
of exertion seen in organized sports to further lower
the risks. However, individual exceptions may be
made if the risk of SCD associated with physical
exertion is clear to the patient and that risk is
deemed acceptable by both the patient and the
cardiologist.
 Asymptomatic ALCA: Due to the higher cumulative
risk of SCD relative to ARCA in our institution we
generally operate on this condition after the age of
10. Prior to surgical intervention, we recommend
restriction from competitive sports or other
recreational activities that approach the level of
exertion seen in organized sports. However, this
approach can be tailored to various factors: level of
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institutional experience with operating on this
lesion.Summary
The fear associated with AAOCA has driven our reliance
on surgery as a primary management approach. We as
providers need to have a meaningful discussion with our
patients – and ourselves – regarding the benefits and po-
tential consequences of referring all such patients for sur-
gery. Close observation, exercise restriction or medical
management may be viable options that are already used
by many providers. For some patients, the risk of SCD
may be untenable, but we need to present that risk hon-
estly – as far rarer then previously thought.
Frommelt noted recently, “Although surgical interven-
tion for some potentially lethal forms of coronary anom-
alies is feasible with good early results, no clear best
practice has been established for the management of
these patients [98].” We hope that this critical analysis of
recent data lends further insights to the debate and we
look forward to the findings of the newly developed
registry studying the natural history and long-term sur-
gical outcomes in AAOCA.Endnote
a “Asymptomatic” in our opinion refers to the absence
of symptoms specifically caused by myocardial ischemia.
We do not consider non-cardiac chest pain a “symptom”
– for example, chest pain that is reproduced on exercise
stress-testing without objective evidence of ischemia or
chest pain that is inconsistent with myocardial ischemia.
Syncope (especially exertional) is a far more worrisome
symptom unless convincingly vasovagal in origin.
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